Answers are grounded in this paper and cite their sources.
Reconstruction of infected soft tissue defects requires a biomaterial providing structural support for tissue regeneration and sustained local infection control. We developed a gentamicin-loaded 3D-printed porcine extracellular matrix (ECM)-derived collagen scaffold and evaluated its in vitro biocompatibility and antibacterial potency. Porcine type I collagen scaffolds were 3D-bioprinted, stabilized by chemical (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-hydroxysuccinimide, EDC/NHS) or physical (dehydrothermal) crosslinking, and loaded with gentamicin. Six groups differing in fabrication, crosslinking, and gentamicin loading, including conventional sponges, were compared. Cell adhesion at 24 h and metabolic activity, proliferation, and infiltration over 7 days were assessed in L929 fibroblasts, and gentamicin potency by microbiological assay. Compared with sponges, 3D-printed scaffolds showed up to 1.46-fold higher 24 h adhesion, significantly higher proliferation, and up to 3.37-fold deeper infiltration (p < 0.001). Chemical crosslinking supported higher day-7 metabolic activity without and with gentamicin (2.05 ± 0.07 and 2.15 ± 0.21) than physical crosslinking (p < 0.05). Gentamicin incorporation did not impair cellular responses to the 3D-printed scaffolds, and antibacterial potency was preserved after fabrication. The scaffold showed favorable preliminary cytocompatibility and preserved antibacterial potency, with EDC/NHS as a promising crosslinking method. These findings support its potential as an implantable biomaterial integrating structural support with expected local antibacterial activity.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: